Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (4166)	12/31/1997 6:19:00 PM
From: Edderd	Respond to of 23519

BKNY3 I like your odds. Thats about my WAG. Ed

To: BigKNY3 who wrote (4166)	1/2/1998 2:08:00 PM
From: Tunica Albuginea	Read Replies (1) \| Respond to of 23519

BigKNY3, I hate, to make prdictions on clinical trials because th eroad to approval is long, the hype high, expectations/delivery ratio variable, and this is for MOST drugs. I suspect however that beccuse of PFE's sheer marketing muscle the pill is likely to come out and tried widely.Only time will tell truly what the side effects are. I think that the impact on Vivus sales will be minimal because MUSE has the advantage of immediacy of action and because people will quickly figure out that you " prime the pump with Viagra and then you turn it loose with MUSE" just a wild medical guess, <gg>. TA